MedPath

Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions

Not Applicable
Completed
Conditions
Type 2 Diabetes
Interventions
Dietary Supplement: White sweet potato formula
Dietary Supplement: Commercial diabetic formula
Registration Number
NCT02711839
Lead Sponsor
Taipei Medical University
Brief Summary

In order to response the increasing of aging population cause losing ability that need long-care needs, the project entitled "10-year long-term care program" from Executive Yuan in 2007 is carried out to assist economically disadvantaged and disabled elderly to acquire daily nutrition. Therefore, the long-term care resident's nutritional status got more attention than before. Out of control in blood glucose will not only increase bed sores and urinary tract infection in tube feeding residents but also rise medical expenditures. The nutritional status of long-term care institutions, anyang homes and nursing home are generally bad in nutrition management due to high cost of nutritional supplements from foreign imports that cause the burden of families. In this study, we will recruit diabetic subjects that divide into white sweet potato group (experimental group) and commercial formula group (control group) by using randomized, parallel and open clinical study through tube feeding in sixty days.

Detailed Description

All subjects will be evaluated the blood sugar and clinical nutrition assessment such as postural measurement, urine test and blood biomarker examination.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Long-term stability nasogastric or gastrostomy-fed person.
  • The physician diagnosed as diabetic and regular use of hypoglycemic drugs.
Exclusion Criteria
  • Psychosis or depression.
  • Hba1c> 8.5%.
  • High taking nutritional supplements or steroids drugs.
  • Have undergone abdominal surgery caused by intestinal sticky.
  • Suffering from cancer, ulcers, respiratory infections and other diseases.
  • Currently receiving central venous nutrition therapy or intravenous nutrition therapy.
  • Liver dysfunction (ALT ≧ 100 U / L), renal insufficiency (creatinine ≧ 3mg / dl), heart failure (NYFc II above), moderate anemia (hemoglobin <9 g / dl).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment GroupWhite sweet potato formulaWhite sweet potato formula
Control GroupCommercial diabetic formulaCommercial diabetic formula
Primary Outcome Measures
NameTimeMethod
HbA1c After Intervention60 days

HbA1c value after 60 days intervention in both groups

Secondary Outcome Measures
NameTimeMethod
Albumin After Intervention60 days

Albumin value after 60 days intervention in both groups

Glucose After Intervention60 days

Glucose value after 60 days intervention in both groups

Total Cholesterol After Intervention60 days

Total cholesterol value after 60 days intervention in both groups

Triglyceride After Intervention60 days

Triglyceride value after 60 days intervention in both groups

© Copyright 2025. All Rights Reserved by MedPath